img

Global Prokinetic Drug Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Prokinetic Drug Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

A prokinetic agent (also gastroprokinetic agent, gastrokinetic agent or propulsive) is a type of drug which enhances gastrointestinal motility by increasing the frequency or strength of contractions, but without disrupting their rhythm. They are used to treat certain gastrointestinal symptoms, including abdominal discomfort, bloating, constipation, heart burn, nausea, and vomiting; and certain gastrointestinal disorders, including irritable bowel syndrome, gastritis, gastroparesis, and functional dyspepsia.
The global Prokinetic Drug market size was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period 2024-2034.
The United States market for Prokinetic Drug is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The China market for Prokinetic Drug is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The Europe market for Prokinetic Drug is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034..
The global key manufacturers of Prokinetic Drug include Sumitomo, Johnson & Johnson, Sanofi, Kyowa Kirin Pharmaceuticals, Pfizer, Teva, Cadila Pharmaceuticals and Hanmi Pharm, etc. In 2022, the global top five players hold a share approximately % in sales volume, and in term of revenue of Prokinetic Drug, the top five companies hold a share nearly %.
In terms of sales (consumption) side, this report focuses on the sales of Prokinetic Drug by regions (Countries), company, by type and by type. from 2018 to 2024 and forecast to 2034.
The global Prokinetic Drug market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Prokinetic Drug market. These figures have been provided in terms of both revenue and sales for the period 2018-2034. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.



By Company


Sumitomo
Johnson & Johnson
Sanofi
Kyowa Kirin Pharmaceuticals
Pfizer
Teva
Cadila Pharmaceuticals
Hanmi Pharm
By Type
Metoclopramide
Domperidone
Cisapride
Others
By Application
Gastroparesis
Constipation
Reflux Esophagitis
Functional Dyspepsia
Sales by Region
North America
U.S.
Canada
China
APAC (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Prokinetic Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3Detailed analysis of Prokinetic Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8China by company, by type and by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Prokinetic Drug sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Report Overview
1.1 Prokinetic Drug Definition
1.2 Market by Type
1.2.1 Global Prokinetic Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Metoclopramide
1.2.3 Domperidone
1.2.4 Cisapride
1.2.5 Others
1.3 Market Segment by Application
1.3.1 Global Prokinetic Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Gastroparesis
1.3.3 Constipation
1.3.4 Reflux Esophagitis
1.3.5 Functional Dyspepsia
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Prokinetic Drug Sales
2.1 Global Prokinetic Drug Revenue Estimates and Forecasts 2018-2034
2.2 Global Prokinetic Drug Revenue by Region: 2018 VS 2022 VS 2034
2.3 Global Prokinetic Drug Revenue by Region
2.3.1 Global Prokinetic Drug Revenue by Region (2018-2024)
2.3.2 Global Prokinetic Drug Revenue by Region (2024-2034)
2.4 Global Prokinetic Drug Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Prokinetic Drug Sales Quantity by Region: 2018 VS 2022 VS 2034
2.6 Global Prokinetic Drug Sales Quantity by Region
2.6.1 Global Prokinetic Drug Sales Quantity by Region (2018-2024)
2.6.2 Global Prokinetic Drug Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Prokinetic Drug Sales Quantity by Manufacturers
3.1.1 Global Prokinetic Drug Sales Quantity by Manufacturers (2018-2024)
3.1.2 Global Prokinetic Drug Sales Quantity Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Companies by Prokinetic Drug Sales in 2022
3.2 Global Prokinetic Drug Revenue by Manufacturers
3.2.1 Global Prokinetic Drug Revenue by Manufacturers (2018-2024)
3.2.2 Global Prokinetic Drug Revenue Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Prokinetic Drug Revenue in 2022
3.3 Global Prokinetic Drug Sales Price by Manufacturers
3.4 Global Key Players of Prokinetic Drug, Industry Ranking, 2021 VS 2022
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Prokinetic Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Prokinetic Drug, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Prokinetic Drug, Product Offered and Application
3.8 Global Key Manufacturers of Prokinetic Drug, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Prokinetic Drug Sales Quantity by Type
4.1.1 Global Prokinetic Drug Historical Sales Quantity by Type (2018-2024)
4.1.2 Global Prokinetic Drug Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Prokinetic Drug Sales Quantity Market Share by Type (2018-2034)
4.2 Global Prokinetic Drug Revenue by Type
4.2.1 Global Prokinetic Drug Historical Revenue by Type (2018-2024)
4.2.2 Global Prokinetic Drug Forecasted Revenue by Type (2024-2034)
4.2.3 Global Prokinetic Drug Revenue Market Share by Type (2018-2034)
4.3 Global Prokinetic Drug Price by Type
4.3.1 Global Prokinetic Drug Price by Type (2018-2024)
4.3.2 Global Prokinetic Drug Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Prokinetic Drug Sales Quantity by Application
5.1.1 Global Prokinetic Drug Historical Sales Quantity by Application (2018-2024)
5.1.2 Global Prokinetic Drug Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Prokinetic Drug Sales Quantity Market Share by Application (2018-2034)
5.2 Global Prokinetic Drug Revenue by Application
5.2.1 Global Prokinetic Drug Historical Revenue by Application (2018-2024)
5.2.2 Global Prokinetic Drug Forecasted Revenue by Application (2024-2034)
5.2.3 Global Prokinetic Drug Revenue Market Share by Application (2018-2034)
5.3 Global Prokinetic Drug Price by Application
5.3.1 Global Prokinetic Drug Price by Application (2018-2024)
5.3.2 Global Prokinetic Drug Price Forecast by Application (2024-2034)
6 North America
6.1 North America Prokinetic Drug Sales by Company
6.1.1 North America Prokinetic Drug Revenue by Company (2018-2024)
6.1.2 North America Prokinetic Drug Sales Quantity by Company (2018-2024)
6.2 North America Prokinetic Drug Market Size by Type
6.2.1 North America Prokinetic Drug Sales Quantity by Type (2018-2034)
6.2.2 North America Prokinetic Drug Revenue by Type (2018-2034)
6.3 North America Prokinetic Drug Market Size by Application
6.3.1 North America Prokinetic Drug Sales Quantity by Application (2018-2034)
6.3.2 North America Prokinetic Drug Revenue by Application (2018-2034)
6.4 North America Prokinetic Drug Market Size by Country
6.4.1 North America Prokinetic Drug Revenue by Country: 2018 VS 2022 VS 2034
6.4.2 North America Prokinetic Drug Revenue by Country (2018-2034)
6.4.3 North America Prokinetic Drug Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Prokinetic Drug Sales by Company
7.1.1 Europe Prokinetic Drug Sales Quantity by Company (2018-2024)
7.1.2 Europe Prokinetic Drug Revenue by Company (2018-2024)
7.2 Europe Prokinetic Drug Market Size by Type
7.2.1 Europe Prokinetic Drug Sales Quantity by Type (2018-2034)
7.2.2 Europe Prokinetic Drug Revenue by Type (2018-2034)
7.3 Europe Prokinetic Drug Market Size by Application
7.3.1 Europe Prokinetic Drug Sales Quantity by Application (2018-2034)
7.3.2 Europe Prokinetic Drug Revenue by Application (2018-2034)
7.4 Europe Prokinetic Drug Market Size by Country
7.4.1 Europe Prokinetic Drug Revenue by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Prokinetic Drug Revenue by Country (2018-2034)
7.4.3 Europe Prokinetic Drug Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Prokinetic Drug Sales by Company
8.1.1 China Prokinetic Drug Sales Quantity by Company (2018-2024)
8.1.2 China Prokinetic Drug Revenue by Company (2018-2024)
8.2 China Prokinetic Drug Market Size by Type
8.2.1 China Prokinetic Drug Sales Quantity by Type (2018-2034)
8.2.2 China Prokinetic Drug Revenue by Type (2018-2034)
8.3 China Prokinetic Drug Market Size by Application
8.3.1 China Prokinetic Drug Sales Quantity by Application (2018-2034)
8.3.2 China Prokinetic Drug Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Prokinetic Drug Sales by Company
9.1.1 APAC Prokinetic Drug Sales Quantity by Company (2018-2024)
9.1.2 APAC Prokinetic Drug Revenue by Company (2018-2024)
9.2 APAC Prokinetic Drug Market Size by Type
9.2.1 APAC Prokinetic Drug Sales Quantity by Type (2018-2034)
9.2.2 APAC Prokinetic Drug Revenue by Type (2018-2034)
9.3 APAC Prokinetic Drug Market Size by Application
9.3.1 APAC Prokinetic Drug Sales Quantity by Application (2018-2034)
9.3.2 APAC Prokinetic Drug Revenue by Application (2018-2034)
9.4 APAC Prokinetic Drug Market Size by Region
9.4.1 APAC Prokinetic Drug Revenue by Region: 2018 VS 2022 VS 2034
9.4.2 APAC Prokinetic Drug Revenue by Region (2018-2034)
9.4.3 APAC Prokinetic Drug Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Prokinetic Drug Sales by Company
10.1.1 Middle East, Africa and Latin America Prokinetic Drug Sales Quantity by Company (2018-2024)
10.1.2 Middle East, Africa and Latin America Prokinetic Drug Revenue by Company (2018-2024)
10.2 Middle East, Africa and Latin America Prokinetic Drug Market Size by Type
10.2.1 Middle East, Africa and Latin America Prokinetic Drug Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Prokinetic Drug Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Prokinetic Drug Market Size by Application
10.3.1 Middle East, Africa and Latin America Prokinetic Drug Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Prokinetic Drug Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Prokinetic Drug Market Size by Country
10.4.1 Middle East, Africa and Latin America Prokinetic Drug Revenue by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa and Latin America Prokinetic Drug Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Prokinetic Drug Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Sumitomo
11.1.1 Sumitomo Company Information
11.1.2 Sumitomo Overview
11.1.3 Sumitomo Prokinetic Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.1.4 Sumitomo Prokinetic Drug Products and Services
11.1.5 Sumitomo Prokinetic Drug SWOT Analysis
11.1.6 Sumitomo Recent Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Information
11.2.2 Johnson & Johnson Overview
11.2.3 Johnson & Johnson Prokinetic Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.2.4 Johnson & Johnson Prokinetic Drug Products and Services
11.2.5 Johnson & Johnson Prokinetic Drug SWOT Analysis
11.2.6 Johnson & Johnson Recent Developments
11.3 Sanofi
11.3.1 Sanofi Company Information
11.3.2 Sanofi Overview
11.3.3 Sanofi Prokinetic Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.3.4 Sanofi Prokinetic Drug Products and Services
11.3.5 Sanofi Prokinetic Drug SWOT Analysis
11.3.6 Sanofi Recent Developments
11.4 Kyowa Kirin Pharmaceuticals
11.4.1 Kyowa Kirin Pharmaceuticals Company Information
11.4.2 Kyowa Kirin Pharmaceuticals Overview
11.4.3 Kyowa Kirin Pharmaceuticals Prokinetic Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.4.4 Kyowa Kirin Pharmaceuticals Prokinetic Drug Products and Services
11.4.5 Kyowa Kirin Pharmaceuticals Prokinetic Drug SWOT Analysis
11.4.6 Kyowa Kirin Pharmaceuticals Recent Developments
11.5 Pfizer
11.5.1 Pfizer Company Information
11.5.2 Pfizer Overview
11.5.3 Pfizer Prokinetic Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.5.4 Pfizer Prokinetic Drug Products and Services
11.5.5 Pfizer Prokinetic Drug SWOT Analysis
11.5.6 Pfizer Recent Developments
11.6 Teva
11.6.1 Teva Company Information
11.6.2 Teva Overview
11.6.3 Teva Prokinetic Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.6.4 Teva Prokinetic Drug Products and Services
11.6.5 Teva Prokinetic Drug SWOT Analysis
11.6.6 Teva Recent Developments
11.7 Cadila Pharmaceuticals
11.7.1 Cadila Pharmaceuticals Company Information
11.7.2 Cadila Pharmaceuticals Overview
11.7.3 Cadila Pharmaceuticals Prokinetic Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.7.4 Cadila Pharmaceuticals Prokinetic Drug Products and Services
11.7.5 Cadila Pharmaceuticals Prokinetic Drug SWOT Analysis
11.7.6 Cadila Pharmaceuticals Recent Developments
11.8 Hanmi Pharm
11.8.1 Hanmi Pharm Company Information
11.8.2 Hanmi Pharm Overview
11.8.3 Hanmi Pharm Prokinetic Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.8.4 Hanmi Pharm Prokinetic Drug Products and Services
11.8.5 Hanmi Pharm Prokinetic Drug SWOT Analysis
11.8.6 Hanmi Pharm Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Prokinetic Drug Value Chain Analysis
12.2 Prokinetic Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Prokinetic Drug Production Mode & Process
12.4 Prokinetic Drug Sales and Marketing
12.4.1 Prokinetic Drug Sales Channels
12.4.2 Prokinetic Drug Distributors
12.5 Prokinetic Drug Customers
13 Market Dynamics
13.1 Prokinetic Drug Industry Trends
13.2 Prokinetic Drug Market Drivers
13.3 Prokinetic Drug Market Challenges
13.4 Prokinetic Drug Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Prokinetic Drug Market Size Growth Rate (CAGR) by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Metoclopramide
Table 3. Major Manufacturers of Domperidone
Table 4. Major Manufacturers of Cisapride
Table 5. Major Manufacturers of Others
Table 6. Global Prokinetic Drug Market Size Growth Rate (CAGR) by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 7. Global Prokinetic Drug Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 8. Global Prokinetic Drug Revenue by Region (2018-2024) & (US$ Million)
Table 9. Global Prokinetic Drug Revenue Market Share by Region (2018-2024)
Table 10. Global Prokinetic Drug Revenue by Region (2024-2034) & (US$ Million)
Table 11. Global Prokinetic Drug Revenue Market Share by Region (2024-2034)
Table 12. Global Prokinetic Drug Sales Quantity by Region: 2018 VS 2022 VS 2034 (K Units)
Table 13. Global Prokinetic Drug Sales by Region (2018-2024) & (K Units)
Table 14. Global Prokinetic Drug Sales Market Share by Region (2018-2024)
Table 15. Global Prokinetic Drug Sales by Region (2024-2034) & (K Units)
Table 16. Global Prokinetic Drug Sales Market Share by Region (2024-2034)
Table 17. Global Prokinetic Drug Sales Quantity by Manufacturers (2018-2024) & (K Units)
Table 18. Global Prokinetic Drug Sales Quantity Share by Manufacturers (2018-2024)
Table 19. Global Prokinetic Drug Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 20. Global Prokinetic Drug Revenue Share by Manufacturers (2018-2024)
Table 21. Global Prokinetic Drug Price by Manufacturers 2018-2024 (US$/Unit)
Table 22. Global Key Players of Prokinetic Drug, Industry Ranking, 2021 VS 2022
Table 23. Global Prokinetic Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Prokinetic Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prokinetic Drug as of 2022)
Table 25. Global Key Manufacturers of Prokinetic Drug, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Prokinetic Drug, Product Offered and Application
Table 27. Global Key Manufacturers of Prokinetic Drug, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Prokinetic Drug Sales Quantity by Type (2018-2024) & (K Units)
Table 30. Global Prokinetic Drug Sales Quantity by Type (2024-2034) & (K Units)
Table 31. Global Prokinetic Drug Sales Quantity Share by Type (2018-2024)
Table 32. Global Prokinetic Drug Sales Quantity Share by Type (2024-2034)
Table 33. Global Prokinetic Drug Revenue by Type (2018-2024) & (US$ Million)
Table 34. Global Prokinetic Drug Revenue by Type (2024-2034) & (US$ Million)
Table 35. Global Prokinetic Drug Revenue Share by Type (2018-2024)
Table 36. Global Prokinetic Drug Revenue Share by Type (2024-2034)
Table 37. Prokinetic Drug Price by Type (2018-2024) & (US$/Unit)
Table 38. Global Prokinetic Drug Price Forecast by Type (2024-2034) & (US$/Unit)
Table 39. Global Prokinetic Drug Sales Quantity by Application (2018-2024) & (K Units)
Table 40. Global Prokinetic Drug Sales Quantity by Application (2024-2034) & (K Units)
Table 41. Global Prokinetic Drug Sales Quantity Share by Application (2018-2024)
Table 42. Global Prokinetic Drug Sales Quantity Share by Application (2024-2034)
Table 43. Global Prokinetic Drug Revenue by Application (2018-2024) & (US$ Million)
Table 44. Global Prokinetic Drug Revenue by Application (2024-2034) & (US$ Million)
Table 45. Global Prokinetic Drug Revenue Share by Application (2018-2024)
Table 46. Global Prokinetic Drug Revenue Share by Application (2024-2034)
Table 47. Prokinetic Drug Price by Application (2018-2024) & (US$/Unit)
Table 48. Global Prokinetic Drug Price Forecast by Application (2024-2034) & (US$/Unit)
Table 49. North America Prokinetic Drug Revenue by Company (2018-2024) & (US$ Million)
Table 50. North America Prokinetic Drug Sales Quantity by Company (2018-2024) & (K Units)
Table 51. North America Prokinetic Drug Sales Quantity by Type (2018-2024) & (K Units)
Table 52. North America Prokinetic Drug Sales Quantity by Type (2024-2034) & (K Units)
Table 53. North America Prokinetic Drug Revenue by Type (2018-2024) & (US$ Million)
Table 54. North America Prokinetic Drug Revenue by Type (2024-2034) & (US$ Million)
Table 55. North America Prokinetic Drug Sales Quantity by Application (2018-2024) & (K Units)
Table 56. North America Prokinetic Drug Sales Quantity by Application (2024-2034) & (K Units)
Table 57. North America Prokinetic Drug Revenue by Application (2018-2024) & (US$ Million)
Table 58. North America Prokinetic Drug Revenue by Application (2024-2034) & (US$ Million)
Table 59. North America Prokinetic Drug Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 60. North America Prokinetic Drug Revenue by Country (2018-2024) & (US$ Million)
Table 61. North America Prokinetic Drug Revenue by Country (2024-2034) & (US$ Million)
Table 62. North America Prokinetic Drug Sales Quantity by Country (2018-2024) & (K Units)
Table 63. North America Prokinetic Drug Sales Quantity by Country (2024-2034) & (K Units)
Table 64. Europe Prokinetic Drug Sales Quantity by Company (2018-2024) & (K Units)
Table 65. Europe Prokinetic Drug Revenue by Company (2018-2024) & (US$ Million)
Table 66. Europe Prokinetic Drug Sales Quantity by Type (2018-2024) & (K Units)
Table 67. Europe Prokinetic Drug Sales Quantity by Type (2024-2034) & (K Units)
Table 68. Europe Prokinetic Drug Revenue by Type (2018-2024) & (US$ Million)
Table 69. Europe Prokinetic Drug Revenue by Type (2024-2034) & (US$ Million)
Table 70. Europe Prokinetic Drug Sales Quantity by Application (2018-2024) & (K Units)
Table 71. Europe Prokinetic Drug Sales Quantity by Application (2024-2034) & (K Units)
Table 72. Europe Prokinetic Drug Revenue by Application (2018-2024) & (US$ Million)
Table 73. Europe Prokinetic Drug Revenue by Application (2024-2034) & (US$ Million)
Table 74. Europe Prokinetic Drug Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 75. Europe Prokinetic Drug Revenue by Country (2018-2024) & (US$ Million)
Table 76. Europe Prokinetic Drug Revenue by Country (2024-2034) & (US$ Million)
Table 77. Europe Prokinetic Drug Sales Quantity by Country (2018-2024) & (K Units)
Table 78. Europe Prokinetic Drug Sales Quantity by Country (2024-2034) & (K Units)
Table 79. China Prokinetic Drug Sales Quantity by Company (2018-2024) & (K Units)
Table 80. China Prokinetic Drug Revenue by Company (2018-2024) & (US$ Million)
Table 81. China Prokinetic Drug Sales Quantity by Type (2018-2024) & (K Units)
Table 82. China Prokinetic Drug Sales Quantity by Type (2024-2034) & (K Units)
Table 83. China Prokinetic Drug Revenue by Type (2018-2024) & (US$ Million)
Table 84. China Prokinetic Drug Revenue by Type (2024-2034) & (US$ Million)
Table 85. China Prokinetic Drug Sales Quantity by Application (2018-2024) & (K Units)
Table 86. China Prokinetic Drug Sales Quantity by Application (2024-2034) & (K Units)
Table 87. China Prokinetic Drug Revenue by Application (2018-2024) & (US$ Million)
Table 88. China Prokinetic Drug Revenue by Application (2024-2034) & (US$ Million)
Table 89. APAC Prokinetic Drug Sales Quantity by Company (2018-2024) & (K Units)
Table 90. APAC Prokinetic Drug Revenue by Company (2018-2024) & (US$ Million)
Table 91. APAC Prokinetic Drug Sales Quantity by Type (2018-2024) & (K Units)
Table 92. APAC Prokinetic Drug Sales Quantity by Type (2024-2034) & (K Units)
Table 93. APAC Prokinetic Drug Revenue by Type (2018-2024) & (US$ Million)
Table 94. APAC Prokinetic Drug Revenue by Type (2024-2034) & (US$ Million)
Table 95. APAC Prokinetic Drug Sales Quantity by Application (2018-2024) & (K Units)
Table 96. APAC Prokinetic Drug Sales Quantity by Application (2024-2034) & (K Units)
Table 97. APAC Prokinetic Drug Revenue by Application (2018-2024) & (US$ Million)
Table 98. APAC Prokinetic Drug Revenue by Application (2024-2034) & (US$ Million)
Table 99. APAC Prokinetic Drug Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 100. APAC Prokinetic Drug Revenue by Region (2018-2024) & (US$ Million)
Table 101. APAC Prokinetic Drug Revenue by Region (2024-2034) & (US$ Million)
Table 102. APAC Prokinetic Drug Sales Quantity by Region (2018-2024) & (K Units)
Table 103. APAC Prokinetic Drug Sales Quantity by Region (2024-2034) & (K Units)
Table 104. Middle East, Africa and Latin America Prokinetic Drug Sales Quantity by Company (2018-2024) & (K Units)
Table 105. Middle East, Africa and Latin America Prokinetic Drug Revenue by Company (2018-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America Prokinetic Drug Sales Quantity by Type (2018-2024) & (K Units)
Table 107. Middle East, Africa and Latin America Prokinetic Drug Sales Quantity by Type (2024-2034) & (K Units)
Table 108. Middle East, Africa and Latin America Prokinetic Drug Revenue by Type (2018-2024) & (US$ Million)
Table 109. Middle East, Africa and Latin America Prokinetic Drug Revenue by Type (2024-2034) & (US$ Million)
Table 110. Middle East, Africa and Latin America Prokinetic Drug Sales Quantity by Application (2018-2024) & (K Units)
Table 111. Middle East, Africa and Latin America Prokinetic Drug Sales Quantity by Application (2024-2034) & (K Units)
Table 112. Middle East, Africa and Latin America Prokinetic Drug Revenue by Application (2018-2024) & (US$ Million)
Table 113. Middle East, Africa and Latin America Prokinetic Drug Revenue by Application (2024-2034) & (US$ Million)
Table 114. Middle East, Africa and Latin America Prokinetic Drug Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 115. Middle East, Africa and Latin America Prokinetic Drug Revenue by Country (2018-2024) & (US$ Million)
Table 116. Middle East, Africa and Latin America Prokinetic Drug Revenue by Country (2024-2034) & (US$ Million)
Table 117. Middle East, Africa and Latin America Prokinetic Drug Sales Quantity by Country (2018-2024) & (K Units)
Table 118. Middle East, Africa and Latin America Prokinetic Drug Sales Quantity by Country (2024-2034) & (K Units)
Table 119. Sumitomo Company Information
Table 120. Sumitomo Description and Overview
Table 121. Sumitomo Prokinetic Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 122. Sumitomo Prokinetic Drug Product and Services
Table 123. Sumitomo Prokinetic Drug SWOT Analysis
Table 124. Sumitomo Recent Developments
Table 125. Johnson & Johnson Company Information
Table 126. Johnson & Johnson Description and Overview
Table 127. Johnson & Johnson Prokinetic Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 128. Johnson & Johnson Prokinetic Drug Product and Services
Table 129. Johnson & Johnson Prokinetic Drug SWOT Analysis
Table 130. Johnson & Johnson Recent Developments
Table 131. Sanofi Company Information
Table 132. Sanofi Description and Overview
Table 133. Sanofi Prokinetic Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 134. Sanofi Prokinetic Drug Product and Services
Table 135. Sanofi Prokinetic Drug SWOT Analysis
Table 136. Sanofi Recent Developments
Table 137. Kyowa Kirin Pharmaceuticals Company Information
Table 138. Kyowa Kirin Pharmaceuticals Description and Overview
Table 139. Kyowa Kirin Pharmaceuticals Prokinetic Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 140. Kyowa Kirin Pharmaceuticals Prokinetic Drug Product and Services
Table 141. Kyowa Kirin Pharmaceuticals Prokinetic Drug SWOT Analysis
Table 142. Kyowa Kirin Pharmaceuticals Recent Developments
Table 143. Pfizer Company Information
Table 144. Pfizer Description and Overview
Table 145. Pfizer Prokinetic Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 146. Pfizer Prokinetic Drug Product and Services
Table 147. Pfizer Prokinetic Drug SWOT Analysis
Table 148. Pfizer Recent Developments
Table 149. Teva Company Information
Table 150. Teva Description and Overview
Table 151. Teva Prokinetic Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 152. Teva Prokinetic Drug Product and Services
Table 153. Teva Prokinetic Drug SWOT Analysis
Table 154. Teva Recent Developments
Table 155. Cadila Pharmaceuticals Company Information
Table 156. Cadila Pharmaceuticals Description and Overview
Table 157. Cadila Pharmaceuticals Prokinetic Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 158. Cadila Pharmaceuticals Prokinetic Drug Product and Services
Table 159. Cadila Pharmaceuticals Prokinetic Drug SWOT Analysis
Table 160. Cadila Pharmaceuticals Recent Developments
Table 161. Hanmi Pharm Company Information
Table 162. Hanmi Pharm Description and Overview
Table 163. Hanmi Pharm Prokinetic Drug Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 164. Hanmi Pharm Prokinetic Drug Product and Services
Table 165. Hanmi Pharm Prokinetic Drug SWOT Analysis
Table 166. Hanmi Pharm Recent Developments
Table 167. Key Raw Materials Lists
Table 168. Raw Materials Key Suppliers Lists
Table 169. Prokinetic Drug Distributors List
Table 170. Prokinetic Drug Customers List
Table 171. Prokinetic Drug Market Trends
Table 172. Prokinetic Drug Market Drivers
Table 173. Prokinetic Drug Market Challenges
Table 174. Prokinetic Drug Market Restraints
Table 175. Research Programs/Design for This Report
Table 176. Key Data Information from Secondary Sources
Table 177. Key Data Information from Primary Sources
List of Figures
Figure 1. Prokinetic Drug Product Picture
Figure 2. Global Prokinetic Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Prokinetic Drug Market Share by Type in 2022 & 2034
Figure 4. Metoclopramide Product Picture
Figure 5. Domperidone Product Picture
Figure 6. Cisapride Product Picture
Figure 7. Others Product Picture
Figure 8. Global Prokinetic Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 9. Global Prokinetic Drug Market Share by Application in 2022 & 2034
Figure 10. Gastroparesis
Figure 11. Constipation
Figure 12. Reflux Esophagitis
Figure 13. Functional Dyspepsia
Figure 14. Prokinetic Drug Report Years Considered
Figure 15. Global Prokinetic Drug Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 16. Global Prokinetic Drug Revenue 2018-2034 (US$ Million)
Figure 17. Global Prokinetic Drug Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 18. Global Prokinetic Drug Sales Quantity 2018-2034 (K Units)
Figure 19. Global Prokinetic Drug Sales Quantity Market Share by Region (2018-2024)
Figure 20. Global Prokinetic Drug Sales Quantity Market Share by Region (2024-2034)
Figure 21. North America Prokinetic Drug Sales Quantity YoY (2018-2034) & (K Units)
Figure 22. North America Prokinetic Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 23. Europe Prokinetic Drug Sales Quantity YoY (2018-2034) & (K Units)
Figure 24. Europe Prokinetic Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 25. China Prokinetic Drug Sales Quantity YoY (2018-2034) & (K Units)
Figure 26. China Prokinetic Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 27. APAC Prokinetic Drug Sales Quantity YoY (2018-2034) & (K Units)
Figure 28. APAC Prokinetic Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 29. Middle East, Africa and Latin America Prokinetic Drug Sales Quantity YoY (2018-2034) & (K Units)
Figure 30. Middle East, Africa and Latin America Prokinetic Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 31. The Top 10 and Top 5 Players Market Share by Prokinetic Drug Sales Quantity in 2022
Figure 32. The Top 10 and Top 5 Players Market Share by Prokinetic Drug Revenue in 2022
Figure 33. Prokinetic Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 34. Global Prokinetic Drug Sales Quantity Market Share by Type (2018-2034)
Figure 35. Global Prokinetic Drug Revenue Market Share by Type (2018-2034)
Figure 36. Global Prokinetic Drug Sales Quantity Market Share by Application (2018-2034)
Figure 37. Global Prokinetic Drug Revenue Market Share by Application (2018-2034)
Figure 38. North America Prokinetic Drug Revenue Market Share by Company in 2022
Figure 39. North America Prokinetic Drug Sales Quantity Market Share by Company in 2022
Figure 40. North America Prokinetic Drug Sales Quantity Market Share by Type (2018-2034)
Figure 41. North America Prokinetic Drug Revenue Market Share by Type (2018-2034)
Figure 42. North America Prokinetic Drug Sales Quantity Market Share by Application (2018-2034)
Figure 43. North America Prokinetic Drug Revenue Market Share by Application (2018-2034)
Figure 44. North America Prokinetic Drug Revenue Share by Country (2018-2034)
Figure 45. North America Prokinetic Drug Sales Quantity Share by Country (2018-2034)
Figure 46. U.S. Prokinetic Drug Revenue (2018-2034) & (US$ Million)
Figure 47. Canada Prokinetic Drug Revenue (2018-2034) & (US$ Million)
Figure 48. Europe Prokinetic Drug Sales Quantity Market Share by Company in 2022
Figure 49. Europe Prokinetic Drug Revenue Market Share by Company in 2022
Figure 50. Europe Prokinetic Drug Sales Quantity Market Share by Type (2018-2034)
Figure 51. Europe Prokinetic Drug Revenue Market Share by Type (2018-2034)
Figure 52. Europe Prokinetic Drug Sales Quantity Market Share by Application (2018-2034)
Figure 53. Europe Prokinetic Drug Revenue Market Share by Application (2018-2034)
Figure 54. Europe Prokinetic Drug Revenue Share by Country (2018-2034)
Figure 55. Europe Prokinetic Drug Sales Quantity Share by Country (2018-2034)
Figure 56. Germany Prokinetic Drug Revenue (2018-2034) & (US$ Million)
Figure 57. France Prokinetic Drug Revenue (2018-2034) & (US$ Million)
Figure 58. U.K. Prokinetic Drug Revenue (2018-2034) & (US$ Million)
Figure 59. Italy Prokinetic Drug Revenue (2018-2034) & (US$ Million)
Figure 60. Russia Prokinetic Drug Revenue (2018-2034) & (US$ Million)
Figure 61. China Prokinetic Drug Sales Quantity Market Share by Company in 2022
Figure 62. China Prokinetic Drug Revenue Market Share by Company in 2022
Figure 63. China Prokinetic Drug Sales Quantity Market Share by Type (2018-2034)
Figure 64. China Prokinetic Drug Revenue Market Share by Type (2018-2034)
Figure 65. China Prokinetic Drug Sales Quantity Market Share by Application (2018-2034)
Figure 66. China Prokinetic Drug Revenue Market Share by Application (2018-2034)
Figure 67. APAC Prokinetic Drug Sales Quantity Market Share by Company in 2022
Figure 68. APAC Prokinetic Drug Revenue Market Share by Company in 2022
Figure 69. APAC Prokinetic Drug Sales Quantity Market Share by Type (2018-2034)
Figure 70. APAC Prokinetic Drug Revenue Market Share by Type (2018-2034)
Figure 71. APAC Prokinetic Drug Sales Quantity Market Share by Application (2018-2034)
Figure 72. APAC Prokinetic Drug Revenue Market Share by Application (2018-2034)
Figure 73. APAC Prokinetic Drug Revenue Share by Region (2018-2034)
Figure 74. APAC Prokinetic Drug Sales Quantity Share by Region (2018-2034)
Figure 75. Japan Prokinetic Drug Revenue (2018-2034) & (US$ Million)
Figure 76. South Korea Prokinetic Drug Revenue (2018-2034) & (US$ Million)
Figure 77. China Taiwan Prokinetic Drug Revenue (2018-2034) & (US$ Million)
Figure 78. Southeast Asia Prokinetic Drug Revenue (2018-2034) & (US$ Million)
Figure 79. India Prokinetic Drug Revenue (2018-2034) & (US$ Million)
Figure 80. Middle East, Africa and Latin America Prokinetic Drug Sales Quantity Market Share by Company in 2022
Figure 81. Middle East, Africa and Latin America Prokinetic Drug Revenue Market Share by Company in 2022
Figure 82. Middle East, Africa and Latin America Prokinetic Drug Sales Quantity Market Share by Type (2018-2034)
Figure 83. Middle East, Africa and Latin America Prokinetic Drug Revenue Market Share by Type (2018-2034)
Figure 84. Middle East, Africa and Latin America Prokinetic Drug Sales Quantity Market Share by Application (2018-2034)
Figure 85. Middle East, Africa and Latin America Prokinetic Drug Revenue Market Share by Application (2018-2034)
Figure 86. Middle East, Africa and Latin America Prokinetic Drug Sales Quantity Share by Country (2018-2034)
Figure 87. Middle East, Africa and Latin America Prokinetic Drug Revenue Share by Country (2018-2034)
Figure 88. Brazil Prokinetic Drug Revenue (2018-2034) & (US$ Million)
Figure 89. Mexico Prokinetic Drug Revenue (2018-2034) & (US$ Million)
Figure 90. Turkey Prokinetic Drug Revenue (2018-2034) & (US$ Million)
Figure 91. Israel Prokinetic Drug Revenue (2018-2034) & (US$ Million)
Figure 92. GCC Countries Prokinetic Drug Revenue (2018-2034) & (US$ Million)
Figure 93. Prokinetic Drug Value Chain
Figure 94. Prokinetic Drug Production Process
Figure 95. Channels of Distribution (Direct Vs Distribution)
Figure 96. Distributors Profiles
Figure 97. Bottom-up and Top-down Approaches for This Report
Figure 98. Data Triangulation
Figure 99. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries